Cargando…

Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease

BACKGROUND: Although traditional lipid parameters and coronary imaging techniques are valuable for cardiovascular disease (CVD) risk prediction, better diagnostic tests are still needed. METHODS: In a prospective, observational study, 795 individuals had extensive cardiometabolic profiling, includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorokin, Alexander V., Patel, Nidhi, Abdelrahman, Khaled M., Ling, Clarence, Reimund, Mart, Graziano, Giorgio, Sampson, Maureen, Playford, Martin P., Dey, Amit K., Reddy, Aarthi, Teague, Heather L., Stagliano, Michael, Amar, Marcelo, Chen, Marcus Y., Mehta, Nehal N., Remaley, Alan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220837/ https://www.ncbi.nlm.nih.gov/pubmed/35389891 http://dx.doi.org/10.1172/jci.insight.159577

Ejemplares similares

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021)

Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults
por: Yang, Zhi-Hong, et al.
Publicado: (2020)

3065 A1BG and ITIH4 proteins are upregulated on HDL of youth with type 1 diabetes and correlate with glycemic control
por: Gourgari, Evgenia, et al.
Publicado: (2019)

Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study
por: Sorokin, Alexander V., et al.
Publicado: (2023)

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study
por: Gourgari, Evgenia, et al.
Publicado: (2019)

Effect of niacin monotherapy on high density lipoprotein composition and function
por: Gordon, Scott M., et al.
Publicado: (2020)

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
por: Mietus-Snyder, Michele, et al.
Publicado: (2022)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
por: Gourgari, Evgenia A., et al.
Publicado: (2017)

Structural flexibility of apolipoprotein E-derived arginine-rich peptides improves their cell penetration capability
por: Takechi-Haraya, Yuki, et al.
Publicado: (2023)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

Abdominal subcutaneous adipose tissue negatively associates with subclinical coronary artery disease in men with psoriasis
por: Teklu, Meron, et al.
Publicado: (2021)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

PET/CT-Based Characterization of 18F-FDG Uptake in Various Tissues Reveals Novel Potential Contributions to Coronary Artery Disease in Psoriatic Arthritis
por: Schwartz, Daniella M., et al.
Publicado: (2022)

Cell-free, high-density lipoprotein–specific phospholipid efflux assay predicts incident cardiovascular disease
por: Sato, Masaki, et al.
Publicado: (2023)

Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis
por: Zhou, Wunan, et al.
Publicado: (2020)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
por: Brodeur, Mathieu R., et al.
Publicado: (2022)

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
por: Berg, Alexander R., et al.
Publicado: (2023)

Potential Immunological Links Between Psoriasis and Cardiovascular Disease
por: Sajja, Aparna P., et al.
Publicado: (2018)

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
por: Jensen, Majken K., et al.
Publicado: (2012)

The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified coronary artery disease burden in psoriasis
por: Zhou, Wunan, et al.
Publicado: (2021)

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ(1)-HDL, α-HDL, and triglyceride-rich lipoproteins
por: Chétiveaux, Maud, et al.
Publicado: (2020)

Effect of metformin on the high‐density lipoprotein proteome in youth with type 1 diabetes
por: Gourgari, Evgenia, et al.
Publicado: (2021)

Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over time
por: Sajja, Aparna, et al.
Publicado: (2020)

Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I
por: Hossain, Mohammad A, et al.
Publicado: (2012)

Transport of Apolipoprotein B-Containing Lipoproteins through Endothelial Cells Is Associated with Apolipoprotein E-Carrying HDL-Like Particle Formation
por: Yang, Hong, et al.
Publicado: (2018)

Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
por: Gomaraschi, Monica, et al.
Publicado: (2011)

β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis
por: Ma, Weilie, et al.
Publicado: (2016)

Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL
por: Yalcinkaya, Mustafa, et al.
Publicado: (2020)

Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes
por: Atehortua, Laura, et al.
Publicado: (2023)

HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review
por: Berdowska, Izabela, et al.
Publicado: (2022)

Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study
por: Yun, Shin Young, et al.
Publicado: (2023)

HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
por: Zhang, Yuling, et al.
Publicado: (2019)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
por: Amar, Marcelo J. A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5iienctn7arbbhcinc2l5m0frg